Company Heart Test Laboratories, Inc.
Equities
HSCS
US42254E3027
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.17 USD | -2.45% | -1.52% | -69.77% |
Business Summary
Number of employees: 12
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular Diagnostic Technology
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -64.17% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -64.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 55 | 25/13/25 |
Danielle Watson
DFI | Director of Finance/CFO | 42 | 01/21/01 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 01/14/01 |
Mark Hilz
COO | Chief Operating Officer | 66 | 25/13/25 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Hilz
COO | Chief Operating Officer | 66 | 25/13/25 |
David R. Wells
BRD | Director/Board Member | 61 | 28/22/28 |
Andrew Simpson
CEO | Chief Executive Officer | 55 | 25/13/25 |
Bruce Bent
BRD | Director/Board Member | 68 | 01/20/01 |
Brian Szymczak
BRD | Director/Board Member | 51 | 01/14/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 655,616 | 550,661 ( 83.99 %) | 0 | 83.99 % |
Company contact information
Heart Test Laboratories, Inc.
550 Reserve Street Suite 360
76092, Southlake
+682 237 7781
http://www.heartsciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-69.77% | 3.47M | |
+0.02% | 3.25B | |
-9.32% | 160M | |
-16.67% | 78.05M |
- Stock Market
- Equities
- HSCS Stock
- Company Heart Test Laboratories, Inc.